Baylis-Hillman Reaction in Polar Solvents
J . Org. Chem., Vol. 67, No. 2, 2002 513
droxyquinuclidine (127 mg, 1.0 mmol) were reacted in water
(1.0 mL). Purification by column chromatography using pe-
troleum ether/diethyl ether (2:1) as eluant gave the adduct as
a colorless oil (120 mg, 40%): Rf 0.27 (petroleum ether/diethyl
ether, 2:1); IR (film) 3420, 2980, 1720 cm-1; 1H NMR (250 MHz;
CDCl3) 1.3 (s, 9H), 5.5 (s, 1H), 5.95 (s, 1H), 6.45 (s, 1H), 7.25-
7.4 (m, 3H), 7.5-7.65 (m, 2H); 13C NMR (101 MHz, CDCl3)
27.7, 79.0 (q, J CF ) 29 Hz), 83.5, 124.5 (q, J CF ) 280 Hz),
126.9, 127.8, 128.2, 128.8, 129.1, 130.1, 135.5, 137.4, 166.2;
MS (EI) (m/z) 302 (M+, 12), 177 (100), 159 (59); HRMS (EI)
(m/z) calcd for C15H17O3F3 302.1130, found 302.1125.
2-[Hyd r oxy(2-ch lor op h en yl)m eth yl]a cr ylic Acid ter t-
Bu tyl Ester . tert-Butyl acrylate (256 mg, 2.0 mmol), o-
chlorobenzaldehyde (141 mg, 1.0 mmol), and 3-hydroxyquinu-
clidine (127 mg, 1.0 mmol) were reacted in water (1.0 mL).
Purification by column chromatography using 5% ethyl acetate
in hexane as eluant gave the adduct as a yellow oil (143 mg,
53%): Rf 0.32 (10% ethyl acetate in hexane); IR (film) 3426,
2933, 1710 cm-1; 1H NMR (250 MHz, CDCl3) 1.45 (s, 9H), 3.2
(d, J ) 4.5 Hz, 1H), 5.54 (t, J ) 1.1 Hz, 1H), 5.95 (bd, J ) 4.5
Hz, 1H), 6.26 (d, J ) 1.1 Hz, 1H), 7.2-7.4 (m, 4H); 13C NMR
(63 MHz, CDCl3) 28.0, 69.5, 87.1, 125.7, 127.0, 128.1, 129.0,
129.4, 132.9, 136.8, 138.7, 165.8; MS (EI) (m/z) 268 (M+, 6),
154 (76), 139 (74), 57 (100). Anal. Calcd for C14H17ClO3: C,
62.6; H 6.4. Found: C, 62.3; H 6.4.
This is presumably due to the superior ability of the ortho
isomer to bind the Lewis acid and thus activate the
aldehyde. Aliphatic aldehydes (Table 6, entries 5 and 6)
coupled efficiently under stoichiometric conditions, but
at the longer reaction times required under the catalytic
conditions, product decomposition was observed. Acti-
vated ketones worked moderately well, but simple ke-
tones (acetone) were not effective (Table 6, entry 7).
Pivaldehyde (Table 6, entry 8) worked moderately well,
and indeed, this is only the second use of pivaldehyde in
the Baylis-Hillman reaction with any Michael acceptor.5
In conclusion, we have developed new conditions for
accelerating the Baylis-Hillman reaction, which we
believe are now the best to date. These improved condi-
tions employ either water as solvent or small amounts
of formamide and Yb(OTf)3. Using the formamide and
Yb(OTf)3, rate enhancements of up to 120-fold have been
achieved in the coupling of methyl acrylate with benzal-
dehyde over standard DABCO-catalyzed reaction. These
new conditions will be particularly appropriate for solid-
phase Baylis-Hillman reactions of acrylates as high
rates without premature cleavage of the ester from the
resin should be achieved. Hindered and deactivated
aldehydes can now be coupled efficiently, and attempts
to encourage unactivated ketones to couple is underway.
2
1
2-Hyd r oxy-3-m eth ylen esu ccin ic Acid 4-ter t-Bu tyl Es-
ter . tert-Butyl acrylate (256 mg, 2.0 mmol), glyoxylic acid
monohydrate (92 mg, 1.0 mmol), triethylamine (101 mg, 1.0
mmol), and 3-hydroxyquinuclidine (127 mg, 1.0 mmol) were
reacted in water (1.0 mL) to give the adduct as a colorless oil
(114 mg, 56%): IR (film) 3580-2350, 2980, 1721 cm-1 1H
;
Exp er im en ta l Section
NMR (250 MHz, CDCl3) 1.45 (s, 9H), 3.1 (bs, 1H), 4.8 (s, 1H),
5.8 (s, 1H), 6.2 (s, 1H), 7.5 (bs, 1H); 13C NMR (63 MHz, CDCl3)
27.9, 70.2, 83.6, 128.9, 137.9, 166.8, 174.2; MS (CI) (m/z) 220
(MNH4+, 83), 203 (MH+, 12), 164 (100), 147 (34); HRMS (CI)
(m/z) calcd for C9H15O5 203.0919, found 203.0919.
Rea gen ts. Methyl, ethyl, and tert-butyl acrylate were used
as purchased. Cyclohexenone, cyclopentenone, formamide, and
all aldehydes were distilled prior to use. DABCO was purified
by sublimation under vacuum prior to use. DMAP and 3-hy-
droxyquinuclidine were used as purchased without further
purification. All Lewis acids (except Ti(OiPr)4) were stored in
a vacuum desiccator and used without further purification.
Ti(OiPr)4 was distilled under reduced pressure prior to use.
Gen er a l P r oced u r e for th e Ba ylis-Hillm a n Rea ction
(Ta bles 1 a n d 2). To a stirred mixture of 2-cyclohexen-1-one
(2.0 mmol) and carbonyl compound (1.0 mmol) in water (1.0
mL) at room temperature was added the amine catalyst (1.0
mmol). The reaction was stopped by dilution with diethyl ether
and washed with 2 M HCl, followed by water. After drying
over sodium sulfate, filtration, and evaporation, the crude
Mon itor in g of Wa ter -Ba sed Rea ction s (Ta ble 4). To a
stirred mixture of tert-butyl acrylate (256 mg, 2.0 mmol),
benzaldehyde (106 mg, 1.0 mmol), and water (1.0 mL) at room
temperature was added 3-hydroxyquinuclidine (127 mg, 1.0
mmol). At selected time points, an aliquot (yield between 0
and 10%) of the reaction mixture was quenched with 2 M HCl/
brine (1:1, 0.5 mL), extracted with CDCl3 (0.5 mL), passed
through a hydrophobic filter (Whatman IPS filter media
1
catalog no. 6987-1299), and analyzed by H NMR.
Mon itor in g of F or m a m id e-Ba sed Rea ction s (Ta ble 4,
En tr y 11). To a stirred mixture of tert-butyl acrylate (256 mg,
2.0 mmol), benzaldehyde (106 mg, 1.0 mmol), and formamide
(225 mg, 5.0 mmol) at room temperature were added ytterbium
triflate (32 mg, 0.05 mmol) and 3-hydroxyquinuclidine (127
mg, 1.0 mmol). At selected time points (yield between 0 and
10%), an aliquot of the reaction mixture was removed, diluted
1
mixture was analyzed by H NMR.
Gen er a l P r oced u r e for th e Ba ylis-Hillm a n Rea ction
(Ta ble 3). To a stirred mixture of tert-butyl acrylate (256 mg,
2.0 mmol) and carbonyl compound (1.0 mmol) in water (1.0
mL) at room temperature was added 3-hydroxyquinuclidine
(127 mg, 1.0 mmol). The reaction was stopped by dilution with
diethyl ether and washed with 2 M HCl, followed by water.
After drying over sodium sulfate, filtration, and evaporation,
the crude mixture was purified by column chromatography.
2-[Hyd r oxy(2-n itr op h en yl)m eth yl]a cr ylic Acid ter t-
Bu tyl Ester . tert-Butyl acrylate (256 mg, 2.0 mmol), o-
nitrobenzaldehyde (151 mg, 1.0 mmol), and 3-hydroxyquinu-
clidine (127 mg, 1.0 mmol) were reacted in water (1.0 mL).
The mixture was purified by column chromatography using
petroleum ether/diethyl ether (1:1) as eluant to produce the
adduct as a yellow oil (233 mg, 80%): Rf 0.3 (petroleum ether/
1
with CDCl3, and analyzed by H NMR.
Gen er a l P r oced u r e for th e Ba ylis-Hillm a n Rea ction
u n d er Op tim u m Ca ta lytic Con d ition s (Ta bles 5 a n d 6).
To a stirred mixture of carbonyl compound (1.0 mmol), Michael
acceptor (1.2 mmol), and formamide (1.25 mmol) at room
temperature under argon was added 3-hydroxyquinuclidine
(0.1 mmol). After the time indicated, the reaction was stopped
by dilution with ether and washed with 2 M HCl, followed by
water. After drying over sodium sulfate, filtration, and evapo-
ration, the crude mixture was purified by column chromatog-
raphy.
Gen er a l P r oced u r e for th e Ba ylis-Hillm a n Rea ction
u n d er Op tim u m Stoich iom etr ic Con d ition s (Ta bles 5
a n d 6). To a stirred mixture of carbonyl compound (1.0 mmol),
Michael acceptor (1.2 mmol), and formamide (5.0 mmol) at
room temperature under argon were added 3-hydroxyquinu-
clidine (1.0 mmol) and Yb(OTf)3 (0.05 mmol). After the time
indicated, the reaction was stopped by dilution with ether and
washed with 2 M HCl, followed by water. After drying over
sodium sulfate, filtration, and evaporation, the crude mixture
was purified by column chromatography.
1
diethyl ether, 1:1); IR (film) 3452, 2932, 1709, 1528 cm-1; H
NMR (250 MHz; CDCl3) 1.3 (s, 9H), 3.7 (bs, 1H), 5.6 (s, 1H),
6.0 (s, 1H), 6.2 (s, 1H), 7.4 (td, J ) 7.5 Hz, 1.5 Hz, 1H), 7.5-
7.65 (m, 2H), 7.85 (d, J ) 7.5 Hz, 1H); 13C NMR (101 MHz,
CDCl3) 27.8, 67.6, 81.7, 124.5, 125.5, 128.6, 128.8, 133.4, 136.6,
+
142.1, 148.5, 165.1; MS (CI) m/z (rel intensity) 297 (MNH4
,
29), 241 (100), 206 (19); HRMS (CI) (m/z) calcd for C14H21O5N2
297.1450, found C14H21O5N2 297.1436. Anal. Calcd for C14H17
NO5: C, 60.2; H 6.1; N 5.0. Found: C, 60.1; H 6.1; N 5.0.
-
2-(2,2,2-Tr iflu or o-1-h ydr oxy-1-ph en yleth yl)acr ylic Acid
ter t-Bu tyl Ester . tert-Butyl acrylate (256 mg, 2.0 mmol),
2,2,2-trifluoroacetophenone (174 mg, 1.0 mmol), and 3-hy-
2-[Hydr oxy(2-m eth oxyph en yl)m eth yl]acr ylic Acid Eth -
yl Ester . Ethyl acrylate (120 mg, 1.2 mmol), o-anisaldehyde